“This is a major recognition of the technology’s potential impact on ocular surgery and the company’s position in the field of high-precision medical robotics.”

For the further development of robot-assisted ocular surgical procedures, Eindhoven-based Medtech start-up Preceyes and the Mount Sinai Health System (US) are starting a strategic collaboration. As part of the collaboration, Mount Sinai has made an equity investment in Preceyes and joins its Board of Directors. A further goal of this collaboration is to support Preceyes’ strategy to enter the US market, after the necessary FDA approvals and clearance process.

Preceyes and Mount Sinai plan to collaborate to further develop ocular surgical procedures that will enable novel high-precision treatments and benefit existing surgical procedures, and eventually to develop and launch the first clinical studies of this exciting technology in the United States.

Read the whole article at Innovation Origins by clicking the button below.

Preceyes is part of the Kadans community in Meulensteen House of Robotics at the TU/e Campus.